(Q51380849)

English

Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome.

scientific article published in June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome. (English)

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

type-1 diabetes

0 references

type 2 diabetes

0 references

metabolic syndrome

1 reference

based on heuristic

inferred from title

author name string

P U Feig

1

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

S Shah

2

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

A Hermanowski-Vosatka

3

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

D Plotkin

4

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

M S Springer

5

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

S Donahue

6

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

C Thach

7

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

E J Klein

8

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

E Lai

9

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

K D Kaufman

10

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

publication date

1 June 2011

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

13

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

498-504

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

6

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

Obesity and cortisol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

11 beta-Hydroxysteroid dehydrogenases: key enzymes in determining tissue-specific glucocorticoid effects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

Glucocorticoids and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

Inhibition of 11beta-HSD1 as a novel treatment for the metabolic syndrome: do glucocorticoids play a role?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

A transgenic model of visceral obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

Clinical assessment of body hair growth in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01375.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2011.01375.X

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21272190

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51380849&oldid=1187239285"